Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000230876 | SCV000284284 | likely benign | Hypertrophic cardiomyopathy | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347860 | SCV002646795 | likely benign | Cardiovascular phenotype | 2020-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV003532064 | SCV004356973 | likely benign | Cardiomyopathy | 2021-10-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003532064 | SCV004832348 | likely benign | Cardiomyopathy | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699073 | SCV001917381 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001726060 | SCV001962862 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001726060 | SCV001979741 | likely benign | not provided | no assertion criteria provided | clinical testing |